This federal contract award, identified as SPE2DB20D1004|SPE2DB25FNCMK, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp. The contract, valued at $2,173.59, is a Delivery Order for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of November 6, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is a for-profit organization registered in the System for Award Management (SAM.gov) until June 2025. The contract is not designated with any set-aside requirements, indicating open competition. In addition to this specific contract, AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/4/25, 10:26 AM